ARTICLE | Company News
InteRNA Technologies, Dana-Farber Cancer Institute deal
November 9, 2009 8:00 AM UTC
InteRNA and the institute will develop microRNA-based therapeutics to treat cancer. InteRNA will provide its lentiviral-based miRNA overexpression library to screen for targets. Further terms were not...